Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole was unchanged today. By the end of trading, Theravance fell $0.69 (-1.9%) to $36.60 on light volume. Throughout the day, 820,253 shares of Theravance exchanged hands as compared to its average daily volume of 1,582,900 shares. The stock ranged in price between $36.13-$37.49 after having opened the day at $37.00 as compared to the previous trading day's close of $37.29. Other companies within the Health Care sector that declined today were:
), down 37.2%,
), down 20.4%,
), down 16.9% and
), down 16.1%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass
Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system (CNS)/pain. Theravance has a market cap of $3.8 billion and is part of the drugs industry. Shares are up 67.7% year to date as of the close of trading on Thursday. Currently there are 6 analysts that rate Theravance a buy, 1 analyst rates it a sell, and 2 rate it a hold.
TheStreet Ratings rates
. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally high debt management risk and feeble growth in its earnings per share.
- You can view the full Theravance Ratings Report.
On the positive front,
), up 56.1%,
), up 49.7%,
), up 24.7% and
), up 19.6% , were all gainers within the health care sector with
) being today's featured health care sector leader.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
) while those bearish on the health care sector could consider
- Find other investment ideas from our top rated ETFs lists.